Reagents and method for therapeutic treatment of multiple sclero

Details Reagents and method for therapeutic treatment of multiple sclero Reagents and method for therapeutic treatment of multiple sclero

1990-05-01

1992-04-07

Goldberg, Jerome D.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

A61K 31415

Patent

active

051029022

ABSTRACT:
The administration internally to humans of certain imidazol derivatives, especially N"-cyano-N-methyl-N'-[2[[(5-methyl-1H-imidazol-4-yl) methyl]thio]-ethyl]-guanidine (cimetidine) or salts thereof, is an effective therapeutic treatment for multiple sclerosis, both acute and chronic. The imidazole moiety is theorized to directly inhibit spread of the virus theorized to cause multiple sclerosis. Treatment of multiple sclerosis with metronidazole with one bolus dose on a frequency of once a day or less and with cimetidine on a frequency of twice per day has been found to be highly efficatious with minimal suppression of the patient's natural immune system and minimal long term peripheral nerve damage.

Affiliated with

Also associated with

Rating

Reagents and method for therapeutic treatment of multiple sclero does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Reagents and method for therapeutic treatment of multiple sclero, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Reagents and method for therapeutic treatment of multiple sclero will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1895625